Regionally, the U.S. Ambulatory Surgical Center market is segmented into five major regions including West US, North East US, South East US, South West US, and Midwest US. The market in West US region is estimated to witness growth by a highest CAGR of 7.7% over the forecast period owing to the presence of a large number of ASCs in the states, such as California, and Washington, backed by the increasing prevalence of obesity, asthma, diabetes, hyper tension, and other fatal diseases amongst the individuals. According to the Ambulatory Surgical Centers Association, California has the highest number of Medicare-certified ambulatory surgical centers than any other U.S. state. In 2021, the state recorded 817 Medicare-certified ambulatory surgical centers. Moreover, increasing burden of heart patients, fueled by up-surge in lifestyle diseases in the region, is estimated to encourage the market growth. The market in the North East US is projected to garner the highest share of 26.09% along with a revenue of USD 8,616 million in 2028, up from USD 7,890 million in 2019. This can be attributed to the high geriatric population in the region, along with increasing demand for cost-effective and selective surgeries. According to the United States Census Bureau, the population aged 65 years and over in New Jersey recorded to be 16.6% in the year 2019. Moreover, in other statistics by the Ambulatory Surgical Centers Association, the number of Medicare-certified ambulatory surgical centers in the North East U.S. is on the rise, with 248 ambulatory surgical centers in New York, 259 centers in New Jersey, and 342 centers in Maryland.
The U.S. ambulatory surgical center market is divided by type into hospital affiliated, and freestanding ASCs, out of which, the freestanding ASCs segment held the largest share of 71.91% in the year 2019 and is estimated to generate a revenue of USD 24,508.2 million in 2028, up from USD 21, 572.1 million in 2019. This segment is also anticipated to grow with the highest CAGR of 7.3% during the forecast period, as the freestanding ASCs offer competitive pricing, and can be accessed by patients easily. On the basis of specialty, the market is bifurcated into single-specialty and multi-specialty centers, out of which, the single specialty centers segment is anticipated to hold the largest market share and further grow with the highest CAGR of 7.1% throughout the forecast period. The market is segmented based on ownership into corporate-physician, hospital-physician, corporate-hospital, corporate only, physician only, and hospital only, out of which, the physician-only segment is expected to attain the largest market revenue of USD 21677.2 million by the end of 2028. On the basis of treatment, the market is segmented into orthopedic surgeries, dental, ophthalmology surgeries, endoscopy, obstetrics/gynecology surgeries, cardiovascular surgeries, pain management, ENT surgeries, neurosurgery, gastrointestinal surgery, plastic surgery, and others, out of which, the gastrointestinal segment held the largest market share in 2019 and is further expected to reach USD 6762.4 million by the end of 2028.
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the U.S. ambulatory surgical center market that are included in our report are TH Medical, AMSURG Corp. (Envision Healthcare), Surgical Care Affiliates, SurgCenter, Regent Surgical Health, ASD Management, Ambulatory Surgical Centers of America, Physicians Endoscopy, LLC, Surgery Partners, and others.
December 10, 2020: Tenet Healthcare Corporation to acquire 45 ambulatory surgery centers (ASCs) from SurgCenter Development.
May 15, 2020: AMSURG, the ambulatory surgical center affiliated with Envision Healthcare, announced a new toolkit to guide ambulatory surgery centers to efficiently treat COVID-19 patients.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Author Credits: Radhika Gupta, Shivam Bhutani
Ans: Increasing prevalence of chronic diseases, rising geriatric population, and high healthcare expenditure for ambulatory surgical centers are the major growth drivers for the market.
Ans: The market is anticipated to attain a CAGR of 6.9% over the forecast period, i.e., 2021-2028.
Ans: Reduced healthcare reimbursement amount is estimated to hamper the market growth.
Ans: The West US region is estimated to provide maximum growth opportunities over the forecast period, owing to the increasing prevalence of diseases, such as, obesity, asthma, diabetes, hypertension, and heart disease.
Ans: The major players in the market are TH Medical, (AMSURG Corp.) Envision Healthcare, Surgical Care Affiliates, SurgCenter, Regent Surgical Health, ASD Management, and others.
Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by type, specialty, ownership, treatment, and by region.
Ans: The freestanding ASCs segment is anticipated to hold 71.9% of the market share in 2019 and is estimated grow at a CAGR of 7.3% over the forecast period and display significant growth opportunities.